BioNTech SE (BNTX) Operating Expenses (2018 - 2025)
Historic Operating Expenses for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to -$802.0 million.
- BioNTech SE's Operating Expenses fell 696.46% to -$802.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.9 billion, marking a year-over-year increase of 160.9%. This contributed to the annual value of -$3.0 billion for FY2024, which is 2142.96% down from last year.
- Per BioNTech SE's latest filing, its Operating Expenses stood at -$802.0 million for Q3 2025, which was down 696.46% from -$709.5 million recorded in Q2 2025.
- BioNTech SE's Operating Expenses' 5-year high stood at -$299.7 million during Q2 2021, with a 5-year trough of -$813.6 million in Q2 2024.
- Over the past 5 years, BioNTech SE's median Operating Expenses value was -$642.4 million (recorded in 2022), while the average stood at -$590.9 million.
- As far as peak fluctuations go, BioNTech SE's Operating Expenses crashed by 13181702298.41% in 2021, and later soared by 1279.23% in 2025.
- BioNTech SE's Operating Expenses (Quarter) stood at -$460.3 million in 2021, then crashed by 39.56% to -$642.4 million in 2022, then dropped by 17.58% to -$755.4 million in 2023, then fell by 2.22% to -$772.2 million in 2024, then dropped by 3.86% to -$802.0 million in 2025.
- Its last three reported values are -$802.0 million in Q3 2025, -$709.5 million for Q2 2025, and -$665.3 million during Q1 2025.